GRIFOLS S A/S (GRFS) Lowered to “Neutral” at JPMorgan Chase & Co.

JPMorgan Chase & Co. downgraded shares of GRIFOLS S A/S (NASDAQ:GRFS) from an overweight rating to a neutral rating in a report released on Wednesday morning.

Other equities research analysts have also recently issued reports about the company. Zacks Investment Research upgraded GRIFOLS S A/S from a hold rating to a buy rating and set a $23.00 price target on the stock in a research report on Wednesday, May 2nd. HSBC upgraded GRIFOLS S A/S from a reduce rating to a hold rating in a research report on Wednesday, March 14th. BidaskClub upgraded GRIFOLS S A/S from a sell rating to a hold rating in a research report on Tuesday, May 15th. Finally, Barclays started coverage on GRIFOLS S A/S in a research report on Friday, June 1st. They set an overweight rating on the stock. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and four have given a buy rating to the stock. GRIFOLS S A/S presently has a consensus rating of Hold and an average price target of $22.50.

GRIFOLS S A/S opened at $24.11 on Wednesday, according to MarketBeat Ratings. The stock has a market cap of $16.78 billion, a price-to-earnings ratio of 21.92, a price-to-earnings-growth ratio of 1.60 and a beta of 1.24. GRIFOLS S A/S has a 52 week low of $19.92 and a 52 week high of $25.18. The company has a current ratio of 3.13, a quick ratio of 1.36 and a debt-to-equity ratio of 1.57.

The business also recently declared a special dividend, which was paid on Tuesday, June 12th. Stockholders of record on Monday, June 4th were given a dividend of $0.0125 per share. This represents a dividend yield of 2.15%. The ex-dividend date was Friday, June 1st. GRIFOLS S A/S’s dividend payout ratio is presently 35.45%.

Several institutional investors and hedge funds have recently made changes to their positions in GRFS. FDx Advisors Inc. increased its position in shares of GRIFOLS S A/S by 5.2% in the fourth quarter. FDx Advisors Inc. now owns 51,725 shares of the biotechnology company’s stock worth $1,186,000 after purchasing an additional 2,558 shares during the last quarter. PNC Financial Services Group Inc. increased its position in shares of GRIFOLS S A/S by 14.9% in the first quarter. PNC Financial Services Group Inc. now owns 20,428 shares of the biotechnology company’s stock worth $433,000 after purchasing an additional 2,656 shares during the last quarter. ETRADE Capital Management LLC increased its position in shares of GRIFOLS S A/S by 16.9% in the first quarter. ETRADE Capital Management LLC now owns 20,010 shares of the biotechnology company’s stock worth $424,000 after purchasing an additional 2,892 shares during the last quarter. First Republic Investment Management Inc. increased its position in shares of GRIFOLS S A/S by 35.0% in the first quarter. First Republic Investment Management Inc. now owns 12,892 shares of the biotechnology company’s stock worth $273,000 after purchasing an additional 3,340 shares during the last quarter. Finally, Blair William & Co. IL increased its position in shares of GRIFOLS S A/S by 9.9% in the first quarter. Blair William & Co. IL now owns 38,960 shares of the biotechnology company’s stock worth $826,000 after purchasing an additional 3,499 shares during the last quarter. Hedge funds and other institutional investors own 21.64% of the company’s stock.

About GRIFOLS S A/S

Grifols, SA, a specialty pharmaceutical company, develops, manufactures, and distributes biological medicines on plasma derived proteins in the United States, Canada, Spain, rest of the European Union, and internationally. The company operates through five segments: Bioscience, Diagnostic, Hospital, Bio Supplies, and Others.

Analyst Recommendations for GRIFOLS S A/S (NASDAQ:GRFS)

Receive News & Ratings for GRIFOLS S A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GRIFOLS S A/S and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit